{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T01:02:20Z","timestamp":1794186140639,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13028-6","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T16:36:26Z","timestamp":1751474186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drug utilization pattern among type II diabetic patients in Palestine"],"prefix":"10.1186","volume":"25","author":[{"given":"Murad","family":"Abualhasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Sweileh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"Pt A","key":"13028_CR1","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.phrs.2016.09.040","volume":"113","author":"P Balakumar","year":"2016","unstructured":"Balakumar P, Maung UK, Jagadeesh G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res. 2016;113(Pt A):600\u20139.","journal-title":"Pharmacol Res"},{"key":"13028_CR2","doi-asserted-by":"publisher","first-page":"108086","DOI":"10.1016\/j.diabres.2020.108086","volume":"162","author":"P Saeedi","year":"2020","unstructured":"Saeedi P, Salpea P, Karuranga S, Petersohn I, Malanda B, Gregg EW, et al. Mortality attributable to diabetes in 20\u201379 years old adults, 2019 estimates: results from the international diabetes federation diabetes atlas, 9(th) edition. Diabetes Res Clin Pract. 2020;162:108086.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"13028_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1109\/MPUL.2014.2309576","volume":"5","author":"I Laher","year":"2014","unstructured":"Laher I. Diabetes and the Arab nations: have we reached a tipping point, and how do we silence the alarm? IEEE Pulse. 2014;5(3):26\u20139.","journal-title":"IEEE Pulse"},{"key":"13028_CR4","doi-asserted-by":"crossref","unstructured":"El Sharif N, Imam A. Current Status of Diabetes in Palestine: Epidemiology, Management, and Healthcare System. Handbook Health c Arab World. 2021:1053-81.","DOI":"10.1007\/978-3-030-36811-1_43"},{"key":"13028_CR5","doi-asserted-by":"crossref","unstructured":"Alhaji JH. Vitamin B12 deficiency in patients with diabetes on metformin: Arab countries. Nutrients. 2022;14(10):2046.","DOI":"10.3390\/nu14102046"},{"key":"13028_CR6","doi-asserted-by":"crossref","unstructured":"Suryasa IW, Rodr\u00edguez-G\u00e1mez M, Koldoris T. Health and treatment of diabetes mellitus. Int J Health Sci. 2021;5(1):2864.","DOI":"10.53730\/ijhs.v5n1.2864"},{"key":"13028_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00125-008-1157-y","volume":"52","author":"D Nathan","year":"2009","unstructured":"Nathan D, Buse J, Davidson M, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American diabetes association and the European association for the study of diabetes. Diabetologia. 2009;52:17\u201330.","journal-title":"Diabetologia"},{"issue":"4","key":"13028_CR8","doi-asserted-by":"publisher","first-page":"e3749","DOI":"10.1016\/j.amjmed.2009.07.017","volume":"123","author":"RM Bergenstal","year":"2010","unstructured":"Bergenstal RM, Bailey CJ, Kendall DM. Type 2 diabetes: assessing the relative risks and benefits of glucose-lowering medications. Am J Med. 2010;123(4):e3749\u201318.","journal-title":"Am J Med"},{"issue":"6","key":"13028_CR9","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4158\/EP.15.6.540","volume":"15","author":"HW Rodbard","year":"2009","unstructured":"Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, et al. Statement by an American association of clinical endocrinologists\/american college of endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009;15(6):540\u201359.","journal-title":"Endocr Pract"},{"issue":"2","key":"13028_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4158\/EP161682.CS","volume":"23","author":"AJ Garber","year":"2017","unstructured":"Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al. Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm\u2013\u20092017 executive summary. Endocr Pract. 2017;23(2):207\u201338.","journal-title":"Endocr Pract"},{"issue":"S 01","key":"13028_CR11","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1055\/a-1018-9106","volume":"127","author":"R Landgraf","year":"2019","unstructured":"Landgraf R, Aberle J, Birkenfeld AL, Gallwitz B, Kellerer M, Klein H, et al. Therapy of type 2 diabetes. Exp Clin Endocrinol Diabetes. 2019;127(S 01):S73\u201392.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"13028_CR12","doi-asserted-by":"crossref","unstructured":"Powers A, Longo D, Fauci A, Kasper D, Hauser S, Jameson J, et al. Harrison\u2019s principles of internal medicine-Diabetes mellitus 18. kiad\u00e1s Rowbotham MC, Goli V, Kunz NR, Lei D. 2004. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain. 2012;110:697\u2013706.","DOI":"10.1016\/j.pain.2004.05.010"},{"issue":"4","key":"13028_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M16-1860","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Barry MJ, Humphrey LL, Forciea MA, Clinical Guidelines Committee of the American College of P, Fitterman N, et al. Oral Pharmacologic treatment of type 2 diabetes mellitus: A clinical practice guideline update from the American college of physicians. Ann Intern Med. 2017;166(4):279\u201390.","journal-title":"Ann Intern Med"},{"key":"13028_CR14","doi-asserted-by":"crossref","unstructured":"Inzucchi SE, Matthews DR, Management of Hyperglycemia in Type 2 Diabetes American Diabetes A, European Association for the Study of Diabetes Position Statement Writing G. Response to Comments on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140\u2013149. Diabetes Care. 2015;38(8):e128-9.","DOI":"10.2337\/dc15-0812"},{"key":"13028_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s11523-018-0604-z","volume":"13","author":"I Eriksson","year":"2018","unstructured":"Eriksson I, Wettermark B, Bergfeldt K. Real-world use and outcomes of olaparib: a population-based cohort study. Target Oncol. 2018;13:725\u201333.","journal-title":"Target Oncol"},{"key":"13028_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s40471-018-0176-6","volume":"5","author":"N Pratt","year":"2018","unstructured":"Pratt N, Roughead E. Assessment of medication safety using only dispensing data. Curr Epidemiol Rep. 2018;5:357\u201369.","journal-title":"Curr Epidemiol Rep"},{"key":"13028_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/DMSO.S38753","volume":"7","author":"Irons BKaMGM","year":"2014","unstructured":"Irons BKaMGM. Drug treatment of type 2 diabetes mellitus in patients for whom Metformin is contraindicated. Diabetes Metabolic Syndrom Obesitytargets Therapy. 2014;7:15\u201324.","journal-title":"Diabetes Metabolic Syndrom Obesitytargets Therapy"},{"key":"13028_CR18","unstructured":"MOH P. Annual Report of the General Administration of Primary Health Care. 2017."},{"key":"13028_CR19","doi-asserted-by":"crossref","unstructured":"Devi KL, Raleng I, Sailo Z, Valte V. Drug utilization among diabetes mellitus patients in a tertiary care hospital in North-East India. 2020.","DOI":"10.18231\/j.ijpp.2020.030"},{"key":"13028_CR20","doi-asserted-by":"crossref","unstructured":"Kleppe M, Lacroix J, Ham J, Midden C. The development of the promas: a probabilistic medication adherence scale. Patient Prefer Adherence.\u00a02015;9(2):355\u201367.","DOI":"10.2147\/PPA.S76749"},{"issue":"8","key":"13028_CR21","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593\u2013603.","journal-title":"Diabetes Care"},{"issue":"4","key":"13028_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2016.19975","volume":"317","author":"RW Beck","year":"2017","unstructured":"Beck RW. Effect of CGM on glycemic control in adults with type 1 diabetes using insulin injections. JAMA. 2017;317(4):371\u20138.","journal-title":"JAMA"},{"issue":"11","key":"13028_CR23","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.2337\/dc13-0331","volume":"36","author":"K Khunti","year":"2013","unstructured":"Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013;36(11):3411\u20137.","journal-title":"Diabetes Care"},{"issue":"3","key":"13028_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","volume":"42","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR. Variations in patients\u2019 adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200\u20139.","journal-title":"Med Care"},{"issue":"8","key":"13028_CR25","doi-asserted-by":"publisher","first-page":"e0220956","DOI":"10.1371\/journal.pone.0220956","volume":"14","author":"D Kana Kadayakkara","year":"2019","unstructured":"Kana Kadayakkara D, Balasubramanian P, Araque K, Davis K, Javed F, Niaki P, et al. Multidisciplinary strategies to treat severe hypoglycemia in hospitalized patients with diabetes mellitus reduce inpatient mortality rate: experience from an academic community hospital. PLoS ONE. 2019;14(8):e0220956.","journal-title":"PLoS ONE"},{"issue":"Supplement1","key":"13028_CR26","first-page":"S6","volume":"39","author":"AD Association","year":"2015","unstructured":"Association AD. 1. Strategies for improving care. Diabetes Care. 2015;39(Supplement1):S6\u201312.","journal-title":"Diabetes Care"},{"issue":"1","key":"13028_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/02813432.2020.1714145","volume":"38","author":"M Sorensen","year":"2020","unstructured":"Sorensen M, Groven KS, Gjelsvik B, Almendingen K, Garnweidner-Holme L. The roles of healthcare professionals in diabetes care: a qualitative study in Norwegian general practice. Scand J Prim Health Care. 2020;38(1):12\u201323.","journal-title":"Scand J Prim Health Care"},{"issue":"3","key":"13028_CR28","first-page":"207","volume":"35","author":"PV Burkhart","year":"2003","unstructured":"Burkhart PV, Sabat\u00e9 E. Adherence to long-term therapies: evidence for action. J Nurs Scholarship Official Pub Sigma Theta Tau Int Honor Soc Nurs. 2003;35(3):207.","journal-title":"J Nurs Scholarship Official Pub Sigma Theta Tau Int Honor Soc Nurs"},{"issue":"3","key":"13028_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10865-007-9147-y","volume":"31","author":"KS Ingersoll","year":"2008","unstructured":"Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31(3):213\u201324.","journal-title":"J Behav Med"},{"issue":"4","key":"13028_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2165\/00002512-200623040-00007","volume":"23","author":"SA Vik","year":"2006","unstructured":"Vik SA, Hogan DB, Patten SB, Johnson JA, Romonko-Slack L, Maxwell CJ. Medication nonadherence and subsequent risk of hospitalisation and mortality among older adults. Drugs Aging. 2006;23(4):345\u201356.","journal-title":"Drugs Aging"},{"issue":"12","key":"13028_CR31","doi-asserted-by":"publisher","first-page":"e0207583","DOI":"10.1371\/journal.pone.0207583","volume":"13","author":"NM Aloudah","year":"2018","unstructured":"Aloudah NM, Scott NW, Aljadhey HS, Araujo-Soares V, Alrubeaan KA, Watson MC. Medication adherence among patients with type 2 diabetes: A mixed methods study. PLoS ONE. 2018;13(12):e0207583.","journal-title":"PLoS ONE"},{"key":"13028_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13690-019-0347-z","volume":"77","author":"L Dehdari","year":"2019","unstructured":"Dehdari L, Dehdari T. The determinants of anti-diabetic medication adherence based on the experiences of patients with type 2 diabetes. Archives Public Health. 2019;77:1\u20139.","journal-title":"Archives Public Health"},{"key":"13028_CR33","doi-asserted-by":"crossref","unstructured":"Wibowo MINA, Yasin NM, Kristina SA, Prabandari YS. Exploring of determinants factors of anti-diabetic medication adherence in several regions of Asia\u2013A systematic review. Patient Prefer Adherence. 2022;16(3):197\u2013215.","DOI":"10.2147\/PPA.S347079"},{"issue":"1","key":"13028_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-021-06355-x","volume":"21","author":"Q Al Saffer","year":"2021","unstructured":"Al Saffer Q, Al-Ghaith T, Alshehri A, Al-Mohammed R, Al Homidi S, Hamza MM, et al. The capacity of primary health care facilities in Saudi arabia: infrastructure, services, drug availability, and human resources. BMC Health Serv Res. 2021;21(1):1\u201315.","journal-title":"BMC Health Serv Res"},{"key":"13028_CR35","unstructured":"WHO. Health under attack in the occupied Palestinian territory. 2023. Retrieved from:\u00a0https:\/\/www.who.int\/."},{"key":"13028_CR36","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2165\/0002512-200825120-00007","volume":"25","author":"DT Lau","year":"2008","unstructured":"Lau DT, Briesacher BA, Mercaldo ND, Halpern L, Osterberg EC, Jarzebowski M, et al. Older patients\u2019 perceptions of medication importance and worth: an exploratory pilot study. Drugs Aging. 2008;25:1061\u201375.","journal-title":"Drugs Aging"},{"issue":"2","key":"13028_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1365-2648.2008.04656.x","volume":"63","author":"A Williams","year":"2008","unstructured":"Williams A, Manias E, Walker R. Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs. 2008;63(2):132\u201343.","journal-title":"J Adv Nurs"},{"issue":"1","key":"13028_CR38","first-page":"158","volume":"27","author":"A Bilal","year":"2015","unstructured":"Bilal A, Riaz M, Shafiq NU, Ahmed M, Sheikh S, Rasheed S. Non-Compliance to Anti-Hypertensive medication and its associated factors among hypertensives. J Ayub Med Coll Abbottabad: JAMC. 2015;27(1):158\u201363.","journal-title":"J Ayub Med Coll Abbottabad: JAMC"},{"issue":"2","key":"13028_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5455\/msm.2016.28.129-132","volume":"28","author":"E Zelko","year":"2016","unstructured":"Zelko E, Klemenc-Ketis Z, Tusek-Bunc K. Medication adherence in elderly with polypharmacy living at home: a systematic review of existing studies. Materia socio-medica. 2016;28(2):129.","journal-title":"Materia socio-medica"},{"issue":"3","key":"13028_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00125-014-3460-0","volume":"58","author":"SE Inzucchi","year":"2015","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American diabetes association and the European association for the study of diabetes. Diabetologia. 2015;58(3):429\u201342.","journal-title":"Diabetologia"},{"issue":"9","key":"13028_CR41","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1007\/s00125-017-4336-x","volume":"60","author":"E Sanchez-Rangel","year":"2017","unstructured":"Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017;60(9):1586\u201393.","journal-title":"Diabetologia"},{"issue":"4","key":"13028_CR42","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.clinthera.2017.02.008","volume":"39","author":"JA Overbeek","year":"2017","unstructured":"Overbeek JA, Heintjes EM, Prieto-Alhambra D, Blin P, Lassalle R, Hall GC, et al. Type 2 diabetes mellitus treatment patterns across europe: A Population-based Multi-database study. Clin Ther. 2017;39(4):759\u201370.","journal-title":"Clin Ther"},{"issue":"12","key":"13028_CR43","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2337\/dci19-0034","volume":"42","author":"MC Riddle","year":"2019","unstructured":"Riddle MC. A verdict for glimepiride: effective and not guilty of cardiovascular harm. Diabetes Care. 2019;42(12):2161\u20133.","journal-title":"Diabetes Care"},{"key":"13028_CR44","first-page":"30","volume":"67","author":"S Tripathi","year":"2019","unstructured":"Tripathi S, Tiwaskar M, Kota S, Parthan G, Dasgupta A, Mohanasundaram S, et al. Need of single pill fixed-dose combination with glimepiride in management of diabetes mellitus. J Assoc Phys. 2019;67:30.","journal-title":"J Assoc Phys"},{"issue":"9","key":"13028_CR45","first-page":"e10700","volume":"12","author":"RK Sahay","year":"2020","unstructured":"Sahay RK, Mittal V, Gopal GR, Kota S, Goyal G, Abhyankar M, et al. Glimepiride and Metformin combinations in diabetes comorbidities and complications: Real-World evidence. Cureus. 2020;12(9):e10700.","journal-title":"Cureus"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13028-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13028-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13028-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T16:36:32Z","timestamp":1751474192000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13028-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13028"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13028-6","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures followed adhered to applicable guidelines and regulations. Before participating, each participant provided verbal informed consent was obtained from each participant. Approval was obtained from the Institutional Review Board (IRB) of An-Najah National University (under the number Mas.12.2020\/1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"891"}}